Eli Lilly’s weight loss candidate eloralintide has shown weight loss of 20% in a phase II study.
发布者:BY MARKETWIRE Maria Outze,转转请注明出处:https://robotalks.cn/following-positive-results-eli-lilly-sends-obesity-candidate-into-phase-iii/
Eli Lilly’s weight loss candidate eloralintide has shown weight loss of 20% in a phase II study.
发布者:BY MARKETWIRE Maria Outze,转转请注明出处:https://robotalks.cn/following-positive-results-eli-lilly-sends-obesity-candidate-into-phase-iii/